Health Canada ICH GCP and MRCT Training - The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

The MRCT Center will be facilitating didactic and case-based learning, presentations, and open discussion for regulators from Health Canada (reviewers and inspectors), and individuals from industry, academia, and non-profit organizations

Learning Objectives:

• Describe the standards of Good Clinical Practice (GCP) and key considerations in Multi-Regional Clinical Trials (MRCTs) design as set out in ICH E6(R2) and ICH E17 guidance, with particular focus on how the guidelines are applied by Health Canada.
• Use case studies, to apply the changes of ICH E6(R2) addendum and ICH E17 to increase the acceptability of MRCT data by multiple regulatory authorities
• Demonstrate practical approaches that Health Canada may take to fulfill the requirements of ICH E6(R2) and ICH E17 consistent with ICH standards

For Regulators:

• Describe and demonstrate best practices to assess clinical trial regulatory submissions by Health Canada, including study design, data packages, essential documents, reports, and filings for alignment with ICH GCP and MRCT
• Describe inspection methodologies that may be taken by Health Canada to assess clinical trial conduct for alignment with ICH GCP and MRCT standards, including review of corrective actions.

For other Stakeholders:

• Gain better understanding and knowledge of Health Canada expectation with regard to compliance with the Canadian clinical trial regulations.
• Gain better understanding and knowledge of Health Canada GCP inspection processes to better prepare for an inspection

Click here to download a Flyer

Deliverables